ArticleActa diabetologica2024

Assessing early tubular protective effects of SGLT2 inhibitor empagliflozin against type 2 diabetes mellitus using functional magnetic resonance imaging.

Chuangbiao Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.